Antiplatelet Activity of Riamilovir under Conditions of Lipopolysaccharide Intoxication.

Spasov, A A; Kucheryavenko, A F; Sirotenko, V S; Gaidukova, K A; Uskov, G M

Spasov, A A; Kucheryavenko, A F; Sirotenko, V S; Gaidukova, K A; Uskov, G M.

Afiliação

Spasov AA; Department of Pharmacology and Bioinformatics, Volgograd State Medical University, Ministry of Health of the Russian Federation, Volgograd, Russia.
Kucheryavenko AF; Department of Pharmacology and Bioinformatics, Volgograd State Medical University, Ministry of Health of the Russian Federation, Volgograd, Russia. aidakucheryavenko@yandex.ru.
Sirotenko VS; Department of Pharmacology and Bioinformatics, Volgograd State Medical University, Ministry of Health of the Russian Federation, Volgograd, Russia.
Gaidukova KA; Department of Pharmacology and Bioinformatics, Volgograd State Medical University, Ministry of Health of the Russian Federation, Volgograd, Russia.
Uskov GM; Department of Pharmacology and Bioinformatics, Volgograd State Medical University, Ministry of Health of the Russian Federation, Volgograd, Russia.

Bull Exp Biol Med ; 173(1): 41-45, 2022 May.

Article em En | MEDLINE | ID: mdl-35616790

Assuntos

Lipopolissacarídeos; Inibidores da Agregação Plaquetária; Animais; Antivirais/farmacologia; Aspirina/farmacologia; Plaquetas; Lipopolissacarídeos/farmacologia; Agregação Plaquetária; Inibidores da Agregação Plaquetária/farmacologia; Ratos; Triazinas; Triazóis

Palavras-chave

LPS; hypercytokinemia; platelet aggregation; riamilovir

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Lipopolissacarídeos Limite: Animals Idioma: En Revista: Bull Exp Biol Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Federação Russa

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google